PPR-029 - Naloxone availability in Australian community pharmacies 2015- 2025: Policy impacts and changes over time

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-029
• By: PICCO, Louisa (Monash Addiction Research Centre, Monash University, Australia)
• Co-author(s): Dr Louisa Picco (Monash Addiction Research Centre, Monash University, Melbourne, Australia)
  Rose Laing (Monash Addiction Research Centre, Monash University, Melbourne, Australia)
  Fred Fox (Monash Addiction Research Centre, Monash University, Melbourne, Australia)
  Monica Jung (Monash Addiction Research Centre, Monash University, Melbourne, Australia)
  Jana Dostal (Monash Addiction Research Centre, Monash University, Melbourne, Australia)
  Suzanne Nielsen (Monash Addiction Research Centre, Monash University, Melbourne, Australia)
  
• Abstract:

  Introduction: Opioid related harms are a global public health concern. In Australia, a range of harm reduction strategies designed to mitigate and reduce opioid related harms have been implemented, including take home naloxone. Naloxone is an opioid antagonist, and when administered promptly, can reverse the effects of an opioid overdose. Prior to ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login